Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Paxlovid”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Early research (Phase 1)Study completedNCT05544786
What this trial is testing

Relative Bioavailability Study of Nirmatrelvir/Ritonavir Oral Powder Relative to the Commercial Tablets and Estimation of the Effect of Food on Bioavailability of the Nirmatrelvir/Ritonavir Oral Powder in Healthy Participants.

Who this might be right for
Biological Availability
Pfizer 12
Testing effectiveness (Phase 2)Looking for participantsNCT07406217
What this trial is testing

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients

Who this might be right for
COVID-19Immunodeficiency
Calmy Alexandra 256
Testing effectiveness (Phase 2)Study completedNCT05576662
What this trial is testing

Paxlovid for Treatment of Long Covid

Who this might be right for
Post-acute Sequelae of SARS-CoV-2 InfectionLong COVID
Stanford University 168
Post-approval studies (Phase 4)UnknownNCT05938140
What this trial is testing

Efficiency and Safety of Paxlovid for COVID-19 Patients With Severe Chronic Kidney Disease

Who this might be right for
COVID-19Renal Insufficiency, Chronic
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT05567952
What this trial is testing

Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Who this might be right for
COVID-19
Pfizer 436
Not applicableUnknownNCT05792865
What this trial is testing

A Registry Study of Patients Hospitalized With Confirmed COVID-19

Who this might be right for
COVID-19
Beijing Chao Yang Hospital 488
Early research (Phase 1)Ended earlyNCT05386472
What this trial is testing

Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

Who this might be right for
COVID-19
Pfizer 25
Testing effectiveness (Phase 2)Study completedNCT05438602
What this trial is testing

Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System

Who this might be right for
COVID-19
Pfizer 158
Not applicableStudy completedNCT06291831
What this trial is testing

Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain.

Who this might be right for
COVID-19
Pfizer 3,011
Not applicableWithdrawnNCT05997485
What this trial is testing

Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco

Who this might be right for
COVID-19 Drug Treatment
Pfizer
Very early researchUnknownNCT05386433
What this trial is testing

Paxlovid in the Treatment of COVID-19 Patients With Uremia

Who this might be right for
COVID-19Uremia
Ruijin Hospital 40
Early research (Phase 1)Study completedNCT05525910
What this trial is testing

Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants

Who this might be right for
Biological AvailabilityHealthy Participants
Pfizer 15
Testing effectiveness (Phase 2)Study completedNCT05965726
What this trial is testing

RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms

Who this might be right for
Long COVID-19Long COVID
Kanecia Obie Zimmerman 964
Not applicableStudy completedNCT06735300
What this trial is testing

Saliva PCR in Pregnant Women with COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19) Pneumonia
National Cheng-Kung University Hospital 37
Post-approval studies (Phase 4)Study completedNCT05366192
What this trial is testing

The Safety of Paxlovid in Hemodialysis Patients With Covid-19

Who this might be right for
Safety Issues
RenJi Hospital 18
Not applicableStudy completedNCT06016556
What this trial is testing

COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia

Who this might be right for
Covid-19
Pfizer 250
Not applicableUnknownNCT05642910
What this trial is testing

The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial

Who this might be right for
SARS-CoV-2 Infection
Southeast University, China 540
Not applicableStudy completedNCT07261085
What this trial is testing

Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions.

Who this might be right for
COVID-19
Pfizer 99,000
Post-approval studies (Phase 4)Looking for participantsNCT06792214
What this trial is testing

Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial

Who this might be right for
SARS CoV-2 Post-Acute Sequelae
Mount Sinai Hospital, Canada 118
Large-scale testing (Phase 3)Active Not RecruitingNCT05852873
What this trial is testing

PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway

Who this might be right for
Post COVID-19 Condition, UnspecifiedSARS-CoV2 InfectionCOVID-19
Haukeland University Hospital 2,000
Next Page